All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
BIO / Bio-Rad Laboratories, Inc.
|
|
|
|
|
|
|
|
CPHD / Cepheid
|
|
|
|
|
|
|
|
PETX / Aratana Therapeutics, Inc.
|
|
|
|
|
|
|
|
NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
|
|
|
|
|
|
|
|
US74975N1054 / RTI Surgical, Inc.
|
|
|
|
|
|
|
|
ENDP / Endo International plc
|
|
|
|
|
|
|
|
CYH / Community Health Systems, Inc.
|
|
|
|
|
|
|
|
AKRX / Akorn, Inc.
|
|
|
|
|
|
|
|
/ Oxford Immunotec Global PLC
|
|
|
|
|
|
|
|
LGND / Ligand Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
ESPR / Esperion Therapeutics, Inc.
|
|
|
|
|
|
|
|
MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
018490100 / Allergan plc
|
|
|
|
|
|
|
|
US29266S3040 / Endologix, Inc.
|
|
|
|
|
|
|
|
STRM / Streamline Health Solutions, Inc.
|
|
|
|
|
|
|
|
878193101 / TearLab Corp
|
|
|
|
|
|
|
|
STAA / STAAR Surgical Company
|
|
|
|
|
|
|
|
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ANGO / AngioDynamics, Inc.
|
|
|
|
|
|
|
|
LCI / Lannett Co., Inc.
|
|
|
|
|
|
|
|
HBIO / Harvard Bioscience, Inc.
|
|
|
|
|
|
|
|
HSTM / HealthStream, Inc.
|
|
|
|
|
|
|
|
CYNA / Cynapsus Therapeutics Inc.
|
|
|
|
|
|
|
|
449575AB5 / Igi Laboratories Inc Bond
|
|
|
|
|
|
|
|
MYGN / Myriad Genetics, Inc.
|
|
|
|
|
|
|
|
G0083B108 / Actavis
|
|
|
|
|
|
|
|
US00163U1060 / AMAG Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
NXTM / NxStage Medical, Inc.
|
|
|
|
|
|
|
|
LMAT / LeMaitre Vascular, Inc.
|
|
|
|
|
|
|
|
AET / Aetna, Inc.
|
|
|
|
|
|
|
|
AMGN / Amgen Inc.
|
|
|
|
|
|
|
|
STKL / SunOpta Inc.
|
|
|
|
|
|
|
|
A / Agilent Technologies, Inc.
|
|
|
|
|
|
|
|
SPNC / Spectranetics Corp. (The)
|
|
|
|
|
|
|
|
LHCG / LHC Group Inc
|
|
|
|
|
|
|
|
FLDM / Standard BioTools Inc
|
|
|
|
|
|
|
|
VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
SNY / Sanofi - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
LLY / Eli Lilly and Company
|
|
|
|
|
|
|
|
STJ / St. Jude Medical, Inc.
|
|
|
|
|
|
|
|
QDEL / QuidelOrtho Corporation
|
|
|
|
|
|
|
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
US00C4U1L353 / Mylan N.V.
|
|
|
|
|
|
|
|
/ Array BioPharma, Inc.
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
VSTM / Verastem, Inc.
|
|
|
|
|
|
|
|
PFE / Pfizer Inc.
|
|
|
|
|
|
|
|
STE / STERIS plc
|
|
|
|
|
|
|
|
CELG / Celgene Corp.
|
|
|
|
|
|
|
|
BDX / Becton, Dickinson and Company
|
|
|
|
|
|
|
|
TECH / Bio-Techne Corporation
|
|
|
|
|
|
|
|
HUM / Humana Inc.
|
|
|
|
|
|
|
|
BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
VCYT / Veracyte, Inc.
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
ALKS / Alkermes plc
|
|
|
|
|
|
|
|
ENZ / Enzo Biochem, Inc.
|
|
|
|
|
|
|
|
NEO / NeoGenomics, Inc.
|
|
|
|
|
|
|
|
ELV / Elevance Health, Inc.
|
|
|
|
|
|
|
|
NVS / Novartis AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ATRC / AtriCure, Inc.
|
|
|
|
|
|
|
|
OMCL / Omnicell, Inc.
|
|
|
|
|
|
|
|